Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

dc.contributor.authorPertesi, Maroulio
dc.contributor.authorVallée, Maxime
dc.contributor.authorWei, Xiaomu
dc.contributor.authorRevuelta, Maria V.
dc.contributor.authorGalia, Perrine
dc.contributor.authorDemangel, Delphine
dc.contributor.authorOliver, Javier
dc.contributor.authorFoll, Matthieu
dc.contributor.authorChen, Siwei
dc.contributor.authorPerrial, Emeline
dc.contributor.authorGarderet, Laurent
dc.contributor.authorCorre, Jill
dc.contributor.authorLeleu, Xavier
dc.contributor.authorBoyle, Eileen M.
dc.contributor.authorDecaux, Olivier
dc.contributor.authorRodon, Philippe
dc.contributor.authorKolb, Brigitte
dc.contributor.authorSlama, Borhane
dc.contributor.authorMineur, Philippe
dc.contributor.authorVoog, Eric
dc.contributor.authorBris, Catherine Le
dc.contributor.authorFontan, Jean
dc.contributor.authorMaigre, Michel
dc.contributor.authorBeaumont, Marie
dc.contributor.authorAzais, Isabelle
dc.contributor.authorSobol, Hagay
dc.contributor.authorVignon, Marguerite
dc.contributor.authorRoyer, Bruno
dc.contributor.authorPerrot, Aurore
dc.contributor.authorFuzibet, Jean-Gabriel
dc.contributor.authorDorvaux, Véronique
dc.contributor.authorAnglaret, Bruno
dc.contributor.authorCony-Makhoul, Pascale
dc.contributor.authorBerthou, Christian
dc.contributor.authorDesquesnes, Florence
dc.contributor.authorPegourie, Brigitte
dc.contributor.authorLeyvraz, Serge
dc.contributor.authorMosser, Laurent
dc.contributor.authorFrenkiel, Nicole
dc.contributor.authorAugeul-Meunier, Karine
dc.contributor.authorLeduc, Isabelle
dc.contributor.authorLeyronnas, Cécile
dc.contributor.authorVoillat, Laurent
dc.contributor.authorCasassus, Philippe
dc.contributor.authorMathiot, Claire
dc.contributor.authorCheron, Nathalie
dc.contributor.authorPaubelle, Etienne
dc.contributor.authorMoreau, Philippe
dc.contributor.authorBignon, Yves-Jean
dc.contributor.authorJoly, Bertrand
dc.contributor.authorBourquard, Pascal
dc.contributor.authorCaillot, Denis
dc.contributor.authorNaman, Hervé
dc.contributor.authorRigaudeau, Sophie
dc.contributor.authorMarit, Gérald
dc.contributor.authorMacro, Margaret
dc.contributor.authorLambrecht, Isabelle
dc.contributor.authorCliquennois, Manuel
dc.contributor.authorVicent, Laure
dc.contributor.authorHelias, Philippe
dc.contributor.authorAvet-Loiseau, Hervé
dc.contributor.authorMoreno Aguado, Víctor
dc.contributor.authorReis, Rui Manuel
dc.contributor.authorVarkonyi, Judit
dc.contributor.authorKruszewski, Marcin
dc.contributor.authorVangsted, Annette Juul
dc.contributor.authorJurczyszyn, Artur
dc.contributor.authorZaucha, Jan Maciej
dc.contributor.authorSainz, Juan
dc.contributor.authorKrawczyk-Kulis, Malgorzata
dc.contributor.authorWątek, Marzena
dc.contributor.authorPelosini, Matteo
dc.contributor.authorIskierka-Jażdżewska, Elzbieta
dc.contributor.authorGrząśko, Norbert
dc.contributor.authorMartínez López, Joaquin
dc.contributor.authorJerez, Andrés
dc.contributor.authorCampa, Daniele
dc.contributor.authorBuda, Gabriele
dc.contributor.authorLesueur, Fabienne
dc.contributor.authorDudziński, Marek
dc.contributor.authorGarcía Sanz, Ramón
dc.contributor.authorNagler, Arnon
dc.contributor.authorRymko, Marcin
dc.contributor.authorJamroziak, Krzysztof
dc.contributor.authorButrym, Aleksandra
dc.contributor.authorCanzian, Federico
dc.contributor.authorObazee, Ofure
dc.contributor.authorNilsson, Björn
dc.contributor.authorKlein, Robert J.
dc.contributor.authorLipkin, Steven M.
dc.contributor.authorMcKay, James D.
dc.contributor.authorDumontet, Charles
dc.date.accessioned2020-10-19T11:10:39Z
dc.date.available2020-10-19T11:10:39Z
dc.date.issued2019-09-01
dc.date.updated2020-10-19T11:10:39Z
dc.description.abstractMultiple myeloma (MM) is the third most common hematological malignancy, after Non-Hodgkin Lymphoma and Leukemia. MM is generally preceded by Monoclonal Gammopathy of Undetermined Significance (MGUS) [1], and epidemiological studies have identified older age, male gender, family history, and MGUS as risk factors for developing MM [2]. The somatic mutational landscape of sporadic MM has been increasingly investigated, aiming to identify recurrent genetic events involved in myelomagenesis. Whole exome and whole genome sequencing studies have shown that MM is a genetically heterogeneous disease that evolves through accumulation of both clonal and subclonal driver mutations [3] and identified recurrently somatically mutated genes, including KRAS, NRAS, FAM46C, TP53, DIS3, BRAF, TRAF3, CYLD, RB1 and PRDM1 [3,4,5].
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec698692
dc.identifier.issn0887-6924
dc.identifier.pmid30967618
dc.identifier.urihttps://hdl.handle.net/2445/171340
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41375-019-0452-6
dc.relation.ispartofLeukemia, 2019, vol. 33, num. 9, p. 2324-2330
dc.relation.urihttps://doi.org/10.1038/s41375-019-0452-6
dc.rightscc by (c) Pertesi et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationMieloma múltiple
dc.subject.classificationGenètica
dc.subject.otherMultiple myeloma
dc.subject.otherGenetics
dc.titleExome sequencing identifies germline variants in DIS3 in familial multiple myeloma
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
698692.pdf
Mida:
1.36 MB
Format:
Adobe Portable Document Format